These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1564129)

  • 1. Evolving pathogens in vulvovaginal candidiasis: implications for patient care.
    Horowitz BJ; Giaquinta D; Ito S
    J Clin Pharmacol; 1992 Mar; 32(3):248-55. PubMed ID: 1564129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis).
    Mendling W; Brasch J; Cornely OA; Effendy I; Friese K; Ginter-Hanselmayer G; Hof H; Mayser P; Mylonas I; Ruhnke M; Schaller M; Weissenbacher ER
    Mycoses; 2015 Mar; 58 Suppl 1():1-15. PubMed ID: 25711406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guideline vulvovaginal candidosis (2010) of the German Society for Gynecology and Obstetrics, the Working Group for Infections and Infectimmunology in Gynecology and Obstetrics, the German Society of Dermatology, the Board of German Dermatologists and the German Speaking Mycological Society.
    Mendling W; Brasch J; ; ; ;
    Mycoses; 2012 Jul; 55 Suppl 3():1-13. PubMed ID: 22519657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal susceptibilities of Candida species isolated from the patients with vaginal candidiasis.
    Nagashima M; Yamagishi Y; Mikamo H
    J Infect Chemother; 2016 Feb; 22(2):124-6. PubMed ID: 26627336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use].
    Saporiti AM; Gómez D; Levalle S; Galeano M; Davel G; Vivot W; Rodero L
    Rev Argent Microbiol; 2001; 33(4):217-22. PubMed ID: 11833253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
    Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibility profile of 200 recent clinical isolates of Candida spp. to topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents.
    Choukri F; Benderdouche M; Sednaoui P
    J Mycol Med; 2014 Dec; 24(4):303-7. PubMed ID: 25442913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on Candida no-albicans species and its relation to recurrent vulvovaginal candidiasis].
    Buitrón García R; Romero Cabello R; Cruz Talonia F; Bonifaz A; Zarama Marquez F
    Ginecol Obstet Mex; 2002 Sep; 70():431-6. PubMed ID: 12448051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High rate of vaginal infections caused by non-C. albicans Candida species among asymptomatic women.
    Dan M; Poch F; Levin D
    Med Mycol; 2002 Aug; 40(4):383-6. PubMed ID: 12230217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The therapy of candida vaginitis and candida vulvovaginitis with a new antimycotic substance, clotrimazole.
    Tamura S; Kuramoto H; Yamada T; Majima H; Miyamoto H
    Curr Med Res Opin; 1973; 1(9):540-6. PubMed ID: 4591822
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of vaginal Candida infections.
    Sobel JD
    Expert Opin Pharmacother; 2002 Aug; 3(8):1059-65. PubMed ID: 12150685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern.
    Bitew A; Abebaw Y
    BMC Womens Health; 2018 Jun; 18(1):94. PubMed ID: 29902998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis.
    Ray D; Goswami R; Banerjee U; Dadhwal V; Goswami D; Mandal P; Sreenivas V; Kochupillai N
    Diabetes Care; 2007 Feb; 30(2):312-7. PubMed ID: 17259500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Identification of Candida species causing vaginitis in Mexican patients].
    Rivera-Sánchez R; Flores-Paz R; Arriaga-Alba M
    Enferm Infecc Microbiol Clin; 2006 Dec; 24(10):634-6. PubMed ID: 17194389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-albicans Candida Vulvovaginitis: Treatment Experience at a Tertiary Care Vaginitis Center.
    Powell AM; Gracely E; Nyirjesy P
    J Low Genit Tract Dis; 2016 Jan; 20(1):85-9. PubMed ID: 26083330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased incidence of vulvovaginal candidiasis caused by Candida glabrata in Jordan.
    Abu-Elteen KH
    Jpn J Infect Dis; 2001 Jun; 54(3):103-7. PubMed ID: 11544399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biofilms and vulvovaginal candidiasis.
    Rodríguez-Cerdeira C; Gregorio MC; Molares-Vila A; López-Barcenas A; Fabbrocini G; Bardhi B; Sinani A; Sánchez-Blanco E; Arenas-Guzmán R; Hernandez-Castro R
    Colloids Surf B Biointerfaces; 2019 Feb; 174():110-125. PubMed ID: 30447520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vulvovaginitis due to fluconazole resistant Candida albicans following self treatment with non-prescribed triazoles.
    Dorrell L; Edwards A
    Sex Transm Infect; 2002 Aug; 78(4):308-9. PubMed ID: 12181480
    [No Abstract]   [Full Text] [Related]  

  • 19. Candida tropicalis vulvovaginitis.
    Horowitz BJ; Edelstein SW; Lippman L
    Obstet Gynecol; 1985 Aug; 66(2):229-32. PubMed ID: 3895072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Terconazole cream for non-Candida albicans fungal vaginitis: results of a retrospective analysis.
    Sood G; Nyirjesy P; Weitz MV; Chatwani A
    Infect Dis Obstet Gynecol; 2000; 8(5-6):240-3. PubMed ID: 11220485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.